Fred R. Hirsch, MD, PhD | Authors


Expert Highlights Importance of Molecular Testing in Patients With Lung Cancer

August 14, 2019

Fred R. Hirsch, MD, PhD, shares a message with oncologists regarding molecular testing in patients with lung cancer. He says the most important message is that molecular characterization of the patient’s tumor must be done in order to best treat the patient.

The Importance of Biomarkers for Lung Cancer

October 08, 2014

Fred R. Hirsch, MD, PhD, Professor of Medicine and Pathology, Associate Director for International Programs, University of Colorado Cancer Center, discusses the importance of biomarkers for lung cancer.